Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice

Patients with nonalcoholic fatty liver disease (NAFLD) are reported to have low growth hormone (GH) production and/or hepatic GH resistance. GH replacement can resolve the fatty liver condition in diet-induced obese rodents and in GH-deficient patients. However, it remains to be determined whether t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordoba-Chacon, Jose, Majumdar, Neena, List, Edward O., Diaz-Ruiz, Alberto, Frank, Stuart J., Manzano, Anna, Bartrons, Ramon, Puchowicz, Michelle, Kopchick, John J., Kineman, Rhonda D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542445/
https://www.ncbi.nlm.nih.gov/pubmed/26015548
http://dx.doi.org/10.2337/db15-0370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542445/
https://www.ncbi.nlm.nih.gov/pubmed/26015548
http://dx.doi.org/10.2337/db15-0370

Ejemplares similares